Idéal Investisseur
Français English
CAC 40 : Market closed
8 082,27 pts
+0.93%


Last updated : 14/05/2026 - 17h35
🏠 Home   ➤    Stock news

Emeis Stock Climbs 3.46% to €15.25, Challenging Resistance at €15.29

Mid-afternoon Thursday, Emeis stock has risen by 3.46% to €15.25 in a SBF 120 that is up by 0.84%. The stock is among the top performers in the index and is nearing its resistance level at €15.29. The annual gain now stands at 30.74%.


Emeis Stock Climbs 3.46% to €15.25, Challenging Resistance at €15.29

Emeis Ranks Among the Leaders of the SBF 120, Testing Resistance at €15.29

Emeis is trading at €15.25 mid-afternoon, just cents away from its identified technical resistance at €15.29. Breaking through this threshold could pave the way to levels not seen for several months. The session is occurring in a positively oriented SBF 120 (+0.84%), with the CAC 40 up by 0.83% at 8,074.73 points. The stock ranks among the strongest rises in the SBF 120, trailing behind Derichebourg, Ubisoft, SES, and Elior. Today's rise brings the annual gain to 30.74%, while the weekly performance remains limited to -0.26%. Over three months, the gain reaches 3.88%.

A Tense Technical Setup Brings the Price Close to the Upper Bollinger Bands

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

The price is now above its three moving averages: MM20 at €14.41 (+5.83%), MM50 at €14.02, and MM200 at €13.74. This configuration confirms the medium-term bullish momentum that started at the beginning of the year. The RSI at 54 remains in a neutral zone, leaving room before a signal of overheating. However, the price is at the upper end of the Bollinger Bands, 92% of the range, close to the upper limit at €15.42. This proximity signals a potential short-term overbought zone. It is worth recalling that the organic growth of 6.3% in the first quarter, published on May 7, and the confirmation of the EBITDAR 2026 guidance (growth exceeding 10%) have shaped the recent trajectory. Sustained crossing of the €15.29 mark is the next technical milestone to watch.



Sector Santé · Etablissements de santé / EHPAD Etablissements de santé


Assurance vie

Context

Period
  • Period: 1T2026
Key reported figures
  • Revenue: 1509M€
Risks mentioned
  • Les mesures de qualité engagées en 2024 et 2025 sont essentielles.
  • La demande de lits devrait dépasser l'offre de 550 000 d'ici 2030.
Opportunities identified
  • Croissance organique de +6,3 % au 1T2026, soutenue par des taux d'occupation améliorés.
  • Réduction de la sensibilité aux pressions inflationnistes grâce à un hedging sur 90 % des dépenses énergétiques.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit